Antimicrobial resistance (AMR) is a growing global public health crisis marked by pathogens ability to withstand drugs that once effectively treated infections.
What is Antimicrobial Resistance?
- AMR occurs when microorganisms—bacteria, viruses, fungi, or parasites change over time and no longer respond to antimicrobials designed to eliminate them.
- This makes infections harder to treat, increases the risks associated with surgeries and chemotherapy, and is leading to what is referred to as the “silent pandemic” of drug-resistant infections.
Key Drivers of AMR:
- Overuse and misuse of antibiotics and other antimicrobials in humans, livestock, and agriculture are major contributors.
- Poor infection prevention and control in healthcare settings accelerates spread.
- Low- and middle-income countries are disproportionately affected due to limited access to quality medicines and diagnostics.
Mechanisms of Resistance:
Microbes can resist antimicrobials through several molecular mechanisms:
- Enzymatic Inactivation: Bacteria produce enzymes (like beta-lactamases) that degrade or modify antibiotics, rendering them ineffective.
- Target Modification: Mutations alter the drug’s binding target preventing its action.
- Reduced Drug Permeability: Changes in the microbial cell membrane limit drug entry.
- Drug Efflux: Efflux pumps expel antimicrobials from the cell before they can act.
- Biofilm Formation: Certain bacteria form biofilms, collective protective layers that shield them from drugs and immune system attacks. Biofilms are implicated in up to 80% of human infections, especially on medical devices.
Public Health Impact:
-
Over 2.8 million antimicrobial-resistant infections occur annually in the United States alone.
-
Globally, AMR is already responsible for over one million deaths per year, especially among older adults; it increases morbidity, mortality, and healthcare costs.
Solutions and Strategies:
-
Rational Antibiotic Use:
Curbing unnecessary prescriptions and restricting antibiotics for viral infections.
-
Surveillance and Monitoring: Intensifying efforts to detect, track, and respond to resistant infections.
-
Research & Development: Investing in new antibiotics, vaccines, diagnostics, and alternative treatments.
-
Improved Infection Control: Enhancing hygiene and preventive measures in hospitals and communities.
-
Global Coordination: Multisectoral collaboration across human health, veterinary medicine, agriculture, and environment is indispensable.
AMR is an urgent problem requiring coordinated global action. Without intervention, the world risks returning to a pre-antibiotic era where minor infections can again prove fatal.https://www.cdc.gov/antimicrobial-resistance/data-research/facts-stats/index.html
www.sciencedirect.com/science/article/pii/S2949916X24000343?
What are some effective methods that individuals, healthcare systems, and governments can implement to control and prevent the spread of antibiotic resistance?
MBH/AB